Newsroom

Placeholder

Dr. Nick Dayan, CAO of TriCore Reference Laboratories, named chair and Mark Fidel, co-founder of RiskSense, named vice-Chair of March for Babies


10/16/2017

Dr. Nick Dayan, CAO of TriCore Reference Laboratories, named chair and Mark Fidel, co-founder of RiskSense, named vice-Chair of March for Babies

Read More
Placeholder

TriCore's First Chief Scientific Officer


08/14/2017

Albuquerque-based TriCore Reference Laboratories has established a new executive role to focus on research, the company announced.

Read More
Placeholder

Defenders of Health Campaign


06/19/2017

TriCore Launches Defenders of Health Statewide Ad Campaign

Read More
Placeholder

Lovelace Health System Selects TriCore


10/31/2016

ALBUQUERQUE (October 31, 2016) – Lovelace Health System announced today that it has selected TriCore Reference Laboratories (TriCore) for inpatient and outpatient laboratory management services at its Albuquerque hospitals.

Read More
Placeholder

Paving the way to integrate two of healthcare's crucial services


08/17/2016

TriCore is joining forces with the University of New Mexico’s (UNM) College of Pharmacy, creating a unique opportunity for pharmacists & laboratorians to partner in the laboratory environment to improve patient outcomes.

Read More
Placeholder

Systemic Mastocytosis Responds to New Drug


07/01/2016

A drug called midostaurin showed promise in an international clinical trial coauthored by University of New Mexico and TriCore Reference Laboratories’ pathologist, Tracy George, MD.

Read More
Placeholder

Mesa Biotech Appoints Leading TriCore Reference Laboratories' Expert to Inaugural Scientific Advisory Board


06/29/2016

Mesa Biotech Inc. announced the formation of their world class scientific advisory board.

Read More
Placeholder

American Medical Technologists Distinguished Achievement Award for 2015.


05/02/2016

TriCore Reference Laboratories’ April Trevizo, MLS, has been selected by the American Medical Technologists Board of Directors to receive the AMT Distinguished Achievement Award. 

Read More

TriCore in the News

With technology developed by TGen, the test allows for rapid definitive diagnosis of Valley Fever

DxNA LLC, a molecular diagnostics
company, today announced the regulatory clearance by the U.S. Food and Drug
Administration (FDA) to market its molecular test for rapid detection of
Coccidioidomycosis (Valley Fever) using DxNA’s GeneSTAT.MDx Coccidioides
test and proprietary GeneSTAT System.

www.dxna.com,12/11/2017

American Healthcare Leader - Switching Gears

World-class cyclist Dina Hannah goes the extra mile inside and out of the office at TriCore Reference Laboratories.

American Healthcare Leader,10/02/2017

Outreach: Forge ahead or accept purchase bid

With the laboratory industry in flux—and many critical determinants of the next few years waiting on policy moves by the new administration and third-party payers—hospital outreach programs could wish for a better time to make existential decisions such as accepting an offer to be purchased.

CAP Today,08/15/2017

3 New Mexicans to Know

I had the pleasure of spending part of this morning with 350 eighth graders from Tony Hillerman Middle School, and it gave me some pleasant perspective.

These kids face the awesomely foreboding prospect of entering high school next year and all the terrifying mysteries that entails. Believe me when I tell you, their parents feel exactly the same way — excited and very, very nauseous.

Albuquerque Business First,05/25/2017

Recent Tweets

Follow us on Twitter

Contact Us

Beth Bailey
beth.bailey@tricore.org